Oramed to Present at the Diabetes Technology Meeting

JERUSALEM, October 24, 2017 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ/TASE: ORMP) (https://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company will participate in the upcoming 17th Annual Diabetes Technology Meeting, November 2 to November 4, 2017, at the Bethesda North Marriott Hotel & Conference Center […]